Photo

Personalise healthcare!

The Old Dominion University in Virginia and Regensburg University Medical Center in Germany are jointly organizing an international conference to discuss recent advances and strategic needs in personalised healthcare (pHealth) care and to foster collaboration between industry and academia.

Photo

Hopes for new treatment

Researchers have discovered a potential new treatment for diabetes by isolating and killing defective cells which prevent the natural production of insulin. The investigation opens the door to a potential therapy for patients with type 1 diabetes.

Photo

Diabetes: an increasing threat to people and society

Approximately 31 million people in the European Union are suffering from diabetes, a devastating disease with severe consequences for patients and their families, but also for the society at large and the economic prosperity of Europe. This week EH Online will focus on innovative strategies in diabetes care and on new management systems to support physicians and patients alike. Moreover, we will…

Photo

Stop transplanted insulin cells from dying

Researchers at Linköping University and Uppsala University in Sweden can show that accumulation of protein aggregatess, amyloid, in the transplanted cells may be causing their death. With the aid of their results, physicians can enhance survival of islets transplants and improve treatment of type 1 diabetes.

Photo

Neurologists — an endangered species?

Irish and German neurology associations warn of an imminent shortage of neurologists. In Ireland, according to experts the situation is “lacking at best” and “catastrophic at worst”. German physicians as well detect increasing deficiencies in neurological care coverage primarily due to an aging population and concomitant morbidity.

Photo

Arsenic pollution causes health disaster

Over 70 million people in Southern Asia ingest involuntary arsenic through the groundwater. Arsenic poisoning is the reason for many instances of ill-health, including a rising number of cancer cases. Researchers from Belfast invented a low-cost technology to provide people with arsenic-free water.

Photo

A sad mood causes a bad heart

The common parlance knew it long before experts paid attention to it: a persons mood can be associated to its heart. But indeed in recent years much attention has been spend to depression following heart attack and its effects on prognosis. On the Congress of the European Society of Cardiology (ESC) two Dutch studies have been introduced indicating that especially somatic and incident depression…

Photo

Gastric bypass undoes diabetes symptoms

French findings support the notion that gastric bypass can rapidly reverse diabetes symptoms' a side-effect that lap-band surgery does not show. The benefit results from a new-found element of glucose production by the intestine which also increases insulin sensitivity and lowers blood sugar.

Spotlight Cholesterol: the role of diet, statins and genetics

The inverse epidemiological association between serum levels of HDL-C and risk of coronary artery disease (CAD) is graded and has been validated in multiple studies. However, there is remaining controversy whether a low HDL-C should not predominantly be considered a marker of poor lifestyle (obesity, lack of exercise, hypertriglyceridemia, diet, etc.), rather than a primary causal agent for…

Primary prevention of CVD: Challenges and Achievements

Lifestyle and risk factor results show that recommended scientific guidelines form a contrast to what is achieved in daily practice in high risk individuals in primary prevention of CVD. Together with its partners the ESC demands a comprehensive and multisdicplinary primary prevention programme involving the high-risk population, their GP's and other health professionals, a health insurance…

Winners of media prize announced

The International Chair on Cardiometabolic Risk (ICCR) is pleased to announce the three winners of the European Media Prize co-sponsored by the ICCR and the Association of European Journalists (AEJ) and launched in November 2007 to reward articles that best inform readers about a growing public health issue: abdominal obesity and related risk of cardiovascular disease.

How save are antiangiogenic and anti-inflammatory drugs really?

Since Rofecoxib (Vioxx) was withdrawn from the worldwide market based on the safety findings of the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, the uncertainty around the cardiovascular safety of NSAIDs and COX-2 inhibitors remains and leaves practitioners with difficult management decisions for the hundreds of millions of patients worldwide who continue to require pain-relieving…

466 show more articles
Subscribe to Newsletter